Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 32,714 |
|
|||||
| News | - | ||||||
| Day High | 3.79 | Low High |
|||||
| Day Low | 3.695 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Design Therapeutics Inc | DSGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.005 | -0.13% | 3.755 | 11:55:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.77 | 3.695 | 3.79 | 3.76 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 353 | 32,714 | $ 3.76 | $ 122,980 | - | 1.94 - 8.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:57:12 | 14 | $ 3.76 | USD |
Design Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 210.01M | 56.00M | - | 0 | -66.86M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Design Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DSGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.72 | 3.965 | 3.51 | 3.74 | 241,909 | 0.035 | 0.94% |
| 1 Month | 4.04 | 4.145 | 3.45 | 3.78 | 291,303 | -0.285 | -7.05% |
| 3 Months | 2.41 | 4.145 | 2.245 | 3.29 | 271,187 | 1.35 | 55.81% |
| 6 Months | 2.07 | 4.145 | 1.96 | 2.69 | 342,201 | 1.69 | 81.40% |
| 1 Year | 6.32 | 8.47 | 1.94 | 3.03 | 467,830 | -2.57 | -40.59% |
| 3 Years | 19.23 | 29.16 | 1.94 | 8.50 | 328,236 | -15.48 | -80.47% |
| 5 Years | 28.00 | 50.00 | 1.94 | 8.94 | 326,535 | -24.25 | -86.59% |
Design Therapeutics Description
| Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. |
